Free Trial

REGENXBIO (RGNX) News Today

REGENXBIO logo
$8.54 -0.53 (-5.84%)
Closing price 04:00 PM Eastern
Extended Trading
$8.62 +0.08 (+0.94%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RGNX Latest News

REGENXBIO Inc. stock logo
Millennium Management LLC Buys 1,061,187 Shares of REGENXBIO Inc. (NASDAQ:RGNX)
Millennium Management LLC raised its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 406.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,322,344 shares of the biotechnology company's stock aft
REGENXBIO Inc. stock logo
BNP Paribas Financial Markets Acquires 75,652 Shares of REGENXBIO Inc. (NASDAQ:RGNX)
BNP Paribas Financial Markets boosted its holdings in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 370.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 96,093 shares of the biotechnology company's stock aft
REGENXBIO Inc. stock logo
Q2 Earnings Forecast for REGENXBIO Issued By Leerink Partnrs
REGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Equities research analysts at Leerink Partnrs increased their Q2 2025 EPS estimates for shares of REGENXBIO in a report issued on Monday, May 19th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company will post earnings of (
REGENXBIO Inc. stock logo
REGENXBIO Inc. (NASDAQ:RGNX) Shares Purchased by Jane Street Group LLC
Jane Street Group LLC lifted its stake in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 325.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 164,911 shares of the biotechnology company's stock after acquiring an additional 126,135 shares dur
REGENXBIO Inc. stock logo
REGENXBIO FY2025 EPS Forecast Reduced by Chardan Capital
REGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Investment analysts at Chardan Capital reduced their FY2025 EPS estimates for REGENXBIO in a research report issued to clients and investors on Wednesday, May 14th. Chardan Capital analyst D. Gataulin now anticipates that the biotechnology company will
FY2025 EPS Estimate for REGENXBIO Decreased by Analyst
REGENXBIO Inc. stock logo
Point72 Asia Singapore Pte. Ltd. Makes New $447,000 Investment in REGENXBIO Inc. (NASDAQ:RGNX)
Point72 Asia Singapore Pte. Ltd. purchased a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 57,841 shares of the biotechnology company's st
REGENXBIO Inc. stock logo
Hudson Bay Capital Management LP Has $2.38 Million Position in REGENXBIO Inc. (NASDAQ:RGNX)
Hudson Bay Capital Management LP boosted its holdings in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 43.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 308,100 shares of the biotechnology compa
REGENXBIO Inc. stock logo
REGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Integral Health Asset Management LLC
Integral Health Asset Management LLC lowered its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 29.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 900,000 shares of the biotechnology company's stock af
REGENXBIO Inc. stock logo
Cubist Systematic Strategies LLC Makes New $2.79 Million Investment in REGENXBIO Inc. (NASDAQ:RGNX)
Cubist Systematic Strategies LLC bought a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 361,313 shares of the biotechnology company's stock, valued at approximately $2,793,000. Cubist Systemati
REGENXBIO Inc. stock logo
Brevan Howard Capital Management LP Buys Shares of 41,160 REGENXBIO Inc. (NASDAQ:RGNX)
Brevan Howard Capital Management LP purchased a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 41,160 shares of the biotechno
REGENXBIO Inc. stock logo
Balyasny Asset Management L.P. Has $9.18 Million Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)
Balyasny Asset Management L.P. lifted its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,187,102 shares of the biotechnology company's stock after buying an add
REGENXBIO Inc. stock logo
REGENXBIO Inc. (NASDAQ:RGNX) Given Average Rating of "Moderate Buy" by Brokerages
REGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) has received an average rating of "Moderate Buy" from the six analysts that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on
REGENXBIO Inc. stock logo
Raymond James Financial Inc. Takes Position in REGENXBIO Inc. (NASDAQ:RGNX)
Raymond James Financial Inc. bought a new stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 73,510 shares of the biotechnology c
REGENXBIO Inc. stock logo
Stifel Financial Corp Buys 39,564 Shares of REGENXBIO Inc. (NASDAQ:RGNX)
Stifel Financial Corp raised its stake in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 26.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 188,844 shares of the biotechnology company's stock
REGENXBIO Inc. stock logo
REGENXBIO (RGNX) Projected to Post Quarterly Earnings on Wednesday
REGENXBIO (NASDAQ:RGNX) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 14. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-14-regenxbio-inc-stock/)
REGENXBIO Inc. stock logo
Hsbc Holdings PLC Acquires 48,310 Shares of REGENXBIO Inc. (NASDAQ:RGNX)
Hsbc Holdings PLC grew its holdings in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 132.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 84,817 shares of the biotechnology company's stock after acqui
REGENXBIO Inc. stock logo
REGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Invesco Ltd.
Invesco Ltd. reduced its position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 61.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 52,128 shares of the biotechnology company's s
REGENXBIO Inc. stock logo
PDT Partners LLC Makes New Investment in REGENXBIO Inc. (NASDAQ:RGNX)
PDT Partners LLC purchased a new stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 63,015 shares of the biotechnology company's stock,
REGENXBIO Inc. stock logo
REGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by CANADA LIFE ASSURANCE Co
CANADA LIFE ASSURANCE Co trimmed its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 84.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,649 shares of the biotechnology company's st
REGENXBIO Inc. stock logo
Legal & General Group Plc Lowers Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)
Legal & General Group Plc lowered its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 63.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 44,823 shares of the biotechnology company's s
REGENXBIO Inc. stock logo
Adage Capital Partners GP L.L.C. Buys Shares of 500,000 REGENXBIO Inc. (NASDAQ:RGNX)
Adage Capital Partners GP L.L.C. bought a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 500,000 shares of the biotechn
REGENXBIO Inc. stock logo
Renaissance Technologies LLC Takes $2.10 Million Position in REGENXBIO Inc. (NASDAQ:RGNX)
Renaissance Technologies LLC acquired a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 271,300 shares of the biotechnology company's stock, valued
REGENXBIO Inc. stock logo
Quantessence Capital LLC Takes $270,000 Position in REGENXBIO Inc. (NASDAQ:RGNX)
Quantessence Capital LLC acquired a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 34,888 shares of the biotechnology company's stock, valued at approximately $270,000. Quantessence Cap
REGENXBIO Inc. stock logo
88,148 Shares in REGENXBIO Inc. (NASDAQ:RGNX) Bought by Walleye Capital LLC
Walleye Capital LLC bought a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 88,148 shares of the biotechnology company's stock, valued at approximately $681
REGENXBIO Inc. stock logo
332,814 Shares in REGENXBIO Inc. (NASDAQ:RGNX) Purchased by Voss Capital LP
Voss Capital LP acquired a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 332,814 shares of the biotechnology company's stock, valued at approximat
REGENXBIO Inc. stock logo
Jump Financial LLC Grows Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)
Jump Financial LLC increased its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 144.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 192,708 shares of the biotechnology company's
REGENXBIO Inc. stock logo
Q2 Earnings Estimate for REGENXBIO Issued By Leerink Partnrs
REGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of REGENXBIO in a research report issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar forecasts that the biotechnology company will earn ($1.49) p
REGENXBIO Inc. stock logo
Q1 Earnings Estimate for REGENXBIO Issued By Leerink Partnrs
REGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of REGENXBIO in a research note issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar expects that the biotechnology company will post earnings of $0.65 p
REGENXBIO Inc. stock logo
XTX Topco Ltd Has $836,000 Stock Position in REGENXBIO Inc. (NASDAQ:RGNX)
XTX Topco Ltd raised its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 720.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,120 shares of the biotechnology company's stock after
REGENXBIO Inc. stock logo
Vanguard Group Inc. Sells 1,383,039 Shares of REGENXBIO Inc. (NASDAQ:RGNX)
Vanguard Group Inc. lessened its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 31.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,985,952 shares of the biotechnology company's stock after selling 1,38
REGENXBIO Inc. stock logo
REGENXBIO Inc. (NASDAQ:RGNX) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of REGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the six research firms that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy
REGENXBIO Inc. stock logo
REGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by ExodusPoint Capital Management LP
ExodusPoint Capital Management LP lessened its position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 44.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 105,668 shares of the biotechnology company's stock after selling 83,4
Get REGENXBIO News Delivered to You Automatically

Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter.

RGNX Media Mentions By Week

RGNX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RGNX
News Sentiment

0.90

0.87

Average
Medical
News Sentiment

RGNX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RGNX Articles
This Week

10

5

RGNX Articles
Average Week

Get REGENXBIO News Delivered to You Automatically

Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:RGNX) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners